Anxiety disorders Mental and Behavioural Disorders
Conditions
Interventions
All participants will be assigned to group cognitive hypnotherapy (GCBH) or standard treatment (ST) in a 1:1 ratio using a computerized block randomization algorithm. All patients will receive general
Sponsors
Universiti Sains Malaysia
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. ICD-10 diagnosis of generalized anxiety disorder, social anxiety disorder and panic disorder 2. Anxiety disorder lasting more than 3 months but not more than 3 years 3. Ability to express and understand simple Chinese characters 4. Informed consent and voluntary participation in the study
Exclusion criteria
Exclusion criteria: 1. Patients with major psychiatric disorders such as depression and bipolar disorder 2. Patients at serious risk of suicide and self-injury 3. Patients with serious cardiovascular diseases such as severe hypertension, diabetes, hyperlipidemia 4. Patients who have had substance dependence or abuse, such as alcohol or drug dependence 5. Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured at baseline week 0 and after treatment at week 6: 1. Anxiety levels in patients with anxiety disorders measured using the Hamilton Anxiety Inventory (HAMA) and Self-Assessment Scales for Anxiety (SAS) 2. Somatic symptoms in patients with anxiety disorders measured using the Somatization Symptom Checklist (SSS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Neuroendocrine levels (plasma cortisol [COR], serum triiodothyronine [T3], thyroid hormone [T4] and thyroid stimulating hormone [TSH]) measured using blood samples at baseline week 0 and after the intervention at week 6 | — |
Countries
China
Contacts
Public ContactZhang Hanyue
Outcome results
None listed